Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Vitrafy Life Sciences Ltd. ( (AU:VFY) ) has issued an update.
Vitrafy Life Sciences Limited announced the release of its Quarterly Activities Report and FY25 Annual Results, scheduled for 30 July 2025 and 5 August 2025, respectively. The company will host an investor webinar on 5 August 2025 to present these results, inviting stakeholders to participate. This announcement highlights Vitrafy’s commitment to transparency and engagement with its investors, potentially impacting its market positioning and stakeholder relations.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.30 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Vitrafy Life Sciences Limited is a company specializing in smart cryopreservation solutions, offering an integrated system that combines proprietary hardware and Lifechain™, a cloud-based software platform. This system ensures the preservation of biomaterial quality, aiding industries in maintaining the integrity of sensitive biological samples. Headquartered in Melbourne, Australia, Vitrafy operates an ISO13485 accredited Manufacturing Facility and Laboratory in Ballarat, Victoria, and is listed on the Australian Securities Exchange (ASX: VFY).
Average Trading Volume: 29,317
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$104.1M
Find detailed analytics on VFY stock on TipRanks’ Stock Analysis page.